NASDAQ Stock Market
@nasdaq.com
Get the latest stock market news, stock information & quotes, data analysis reports, as well as a general overview of the market landscape from Nasdaq.
0 Sleduje
0 Sledující
Příspěvky
Odpovědi
Výběr
Média
Lajky
www.nasdaq.com
Better Potential IPO in 2026: SpaceX vs. OpenAI (ChatGPT)
If they do go public, they could end up with valuations of $1 trillion or more and raise the most money ever.
www.nasdaq.com
IREN's GPU Expansion Accelerates: Is Revenue Visibility Improving?
IREN Limited's IREN expanding GPU footprint is increasingly driving its revenue visibility and stock performance. During the first quarter of fiscal 2026, the company advanced its strategy through a landmark, multi-year AI Cloud contract with Microsoft, confirming its hyperscale AI capabilities and establishing a stable revenue base as GPU deployments ramp through 2026.
www.nasdaq.com
IREN's GPU Expansion Accelerates: Is Revenue Visibility Improving?
IREN Limited's IREN expanding GPU footprint is increasingly driving its revenue visibility and stock performance.
#Investing #RenewableEnergy #StockMarket
www.nasdaq.com
Alto Ingredients Surges 45% in a Year: Time to Buy the Stock?
Shares of Alto Ingredients ALTO have gained 45. 4% in a year, outperforming the industry, its sector as well as the Zacks S&P 500 composite.
#Healthcare #AI #Personalization
www.nasdaq.com
Hims & Hers Expands Data-Driven, AI-Enabled Care and Personalization
The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, positions data and AI as central to building a more personalized, scalable healthcare experience, where every customer interaction strengthens the platform.
#Healthcare #AI #Personalization
www.nasdaq.com
Hims & Hers Expands Data-Driven, AI-Enabled Care and Personalization
The renowned health and wellness platform, Hims & Hers Health, Inc.
#Momentus #AdditiveManufacturing #SpaceTech
www.nasdaq.com
Momentus Stock Surges 58% After Additive-Manufactured Fuel Tank Development Announcement
(RTTNews) - Momentus Inc. (MNTS) shares jumped 57. 67%, trading at $9. 05, up $3. 31, following news that the company has developed an additive-manufactured fuel tank under a strategic collaboration to support future space mission needs.
#Momentus #AdditiveManufacturing #SpaceTech
www.nasdaq.com
Momentus Stock Surges 58% After Additive-Manufactured Fuel Tank Development Announcement
(RTTNews) - Momentus Inc.
#Cognizant #MicrosoftAzure #AI
www.nasdaq.com
Cognizant's 3Cloud Buyout to Accelerate AI Transformation for Clients
Cognizant Technology Solutions CTSH has completed the previously announced acquisition of 3Cloud, a leading Microsoft MSFT Azure services provider.
#Cognizant #MicrosoftAzure #AI
www.nasdaq.com
Cognizant's 3Cloud Buyout to Accelerate AI Transformation for Clients
Cognizant Technology Solutions CTSH has completed the previously announced acquisition of 3Cloud, a leading Microsoft MSFT Azure services provider.
www.nasdaq.com
Can Intel's Xeon 6900 Processors Drive Long-Term Growth?
Intel Corporation's (INTC) Xeon 6900 processors have many high-performance cores, faster memory, and built-in AI acceleration, making them ideal for data centers, cloud, and AI workloads.
www.nasdaq.com
Can Intel's Xeon 6900 Processors Drive Long-Term Growth?
Intel Corporation's (INTC) Xeon 6900 processors have many high-performance cores, faster memory, and built-in AI acceleration, making them ideal for data centers, cloud, and AI workloads.
#HomeDepot #ConstructionTechnology #ContractorTools
www.nasdaq.com
Can Home Depot's New Pro Tools Accelerate Large-Project Wins?
The Home Depot, Inc. HD has been sharpening its focus on complex, high-value professional work by introducing digital tools that reduce the time and friction contractors face when bidding and executing large projects.
#ArtificialIntelligence #CloudComputing #Networking
www.nasdaq.com
Can Surging AI Cloud Orders Power Ciena's FY26 Revenue Expansion?
Ciena Corporation CIEN has entered fiscal 2026 with growing momentum as artificial intelligence (AI) reshapes global network infrastructure needs.
#ArtificialIntelligence #CloudComputing #Networking
www.nasdaq.com
Can Surging AI Cloud Orders Power Ciena's FY26 Revenue Expansion?
Ciena Corporation CIEN has entered fiscal 2026 with growing momentum as artificial intelligence (AI) reshapes global network infrastructure needs.
www.nasdaq.com
PKX Advances LFP Cathode Materials Business With New JV
POSCO Holdings Inc. 's PKX POSCO Future M is focusing its push on lithium iron phosphate (LFP) cathode materials after signing a joint venture agreement with CNGR and its Korean subsidiary, FINO.
www.nasdaq.com
PKX Advances LFP Cathode Materials Business With New JV
POSCO Holdings Inc.
#SolarEnergy #RenewableEnergy #CleanTech
www.nasdaq.com
GLW Rides on Strength in Solar Market: A Sign of More Upside?
Corning Incorporated GLW is benefiting from solid market traction in its U. S. -made solar product portfolio. This is driving growth in the company's Hemlock and Emerging Growth Businesses.
#SolarEnergy #RenewableEnergy #CleanTech
www.nasdaq.com
GLW Rides on Strength in Solar Market: A Sign of More Upside?
Corning Incorporated GLW is benefiting from solid market traction in its U.
#Biotechnology #AutoimmuneDiseases #ClinicalTrials
www.nasdaq.com
Jade Biosciences To Report Phase I Trial Of JADE101 In 1H2026
(RTTNews) - Jade Biosciences, Inc. (JBIO), a clinical-stage biotechnology company developing therapies for autoimmune diseases, announced its 2026 strategic priorities on Monday, including anticipated milestones before the 44th Annual J.
#Biotechnology #AutoimmuneDiseases #ClinicalTrials
www.nasdaq.com
Jade Biosciences To Report Phase I Trial Of JADE101 In 1H2026
(RTTNews) - Jade Biosciences, Inc.
#DominionEnergy #CleanEnergy #Investing
www.nasdaq.com
Dominion Energy Trades Above 200-Day SMA: How to Play the Stock?
Dominion Energy D trading above its 200-day SMA signals a bullish momentum. The company's continued investments in electric and natural gas infrastructure, coupled with a growing focus on renewable energy, underpin its growth outlook.
#DominionEnergy #CleanEnergy #Investing
www.nasdaq.com
Dominion Energy Trades Above 200-Day SMA: How to Play the Stock?
Dominion Energy D trading above its 200-day SMA signals a bullish momentum.
#HybridAI #ConversationalIntelligence #SpeechRecognition
www.nasdaq.com
How SoundHound's Hybrid AI Model Beats Pure LLM Players
SoundHound AI's SOUN competitive edge lies in its hybrid AI architecture, which blends proprietary deterministic models with large language models (LLMs), rather than relying on LLMs alone.
#WeightManagement #ObesityTreatment #PharmaceuticalInnovation
www.nasdaq.com
Will NVO's Wegovy Pill Approval for Obesity be a Game Changer in 2026?
Last month, Novo Nordisk NVO announced the FDA approval of the Wegovy pill (once-daily oral semaglutide 25 mg) to reduce excess body weight and maintain weight reduction in the long term, and to reduce the risk of major adverse cardiovascular (CV) events.
#WeightManagement #ObesityTreatment #PharmaceuticalInnovation
www.nasdaq.com
Will NVO's Wegovy Pill Approval for Obesity be a Game Changer in 2026?
Last month, Novo Nordisk NVO announced the FDA approval of the Wegovy pill (once-daily oral semaglutide 25 mg) to reduce excess body weight and maintain weight reduction in the long term, and to reduce the risk of major adverse cardiovascular (CV) events.
#Hologic #StockMarket #Diagnostics
www.nasdaq.com
Hologic Trading Near 52-Week High: How Should You Play the Stock?
Shares of Hologic HOLX closed the first trading session of the year at $74.
#QuantumComputing #HealthcareInnovation #StrategicPartnerships
www.nasdaq.com
IonQ Expands Strategic Partnerships to Drive Real-World Quantum Use
IonQ IONQ has recently expanded its strategic footprint through a series of high-impact partnerships spanning healthcare, logistics, and academic research, underscoring its ambition to drive real-world adoption of quantum computing.
#QuantumComputing #HealthcareInnovation #StrategicPartnerships
www.nasdaq.com
IonQ Expands Strategic Partnerships to Drive Real-World Quantum Use
IonQ IONQ has recently expanded its strategic footprint through a series of high-impact partnerships spanning healthcare, logistics, and academic research, underscoring its ambition to drive real-world adoption of quantum computing.
#Investment #Energy #Infrastructure
www.nasdaq.com
Here's Why You Should Include PEG Stock in Your Portfolio Now
Public Service Enterprise Group PEG continues to invest consistently in infrastructure modernization to enhance service reliability for its customers.
#RenewableEnergy #InvestmentOpportunities #EnergySector
www.nasdaq.com
AES Stock Rises 28.6% in 6 Months: What Should Investors Do?
The AES Corporation AES shares have gained 28. 6% over the past six months compared with the Zacks Utility-Electric Power industry's growth of 8.
#RenewableEnergy #InvestmentOpportunities #EnergySector
www.nasdaq.com
AES Stock Rises 28.6% in 6 Months: What Should Investors Do?
The AES Corporation AES shares have gained 28.
#Iren #BitcoinMining #ArtificialIntelligence
www.nasdaq.com
This Is One of the Best Artificial Intelligence (AI) Stocks to Hold for the Next 10 Years
Shares of Iren (NASDAQ: IREN) more than tripled in 2025. The Bitcoin miner, founded in 2018, is pursuing a massive opportunity by offering its data centers for artificial intelligence (AI) cloud services.
#Neuroscience #Alzheimers #ClinicalTrials
www.nasdaq.com
NMRA Surges On Clinically Meaningful Results In Phase 1 Alzheimer's Disease Agitation Study
(RTTNews) - Neumora Therapeutics, Inc. (NMRA) has entered 2026 with momentum, announcing positive Phase 1b results for its lead candidate NMRA-511 in Alzheimer's disease agitation, along with a pipeline strategy that promises multiple clinical readouts across its neuroscience programs.
#Neuroscience #Alzheimers #ClinicalTrials
www.nasdaq.com
NMRA Surges On Clinically Meaningful Results In Phase 1 Alzheimer's Disease Agitation Study
(RTTNews) - Neumora Therapeutics, Inc.
www.nasdaq.com
Will NVDA's Blackwell Platform Support Its Data Center Revenue Growth?
NVIDIA Corporation's NVDA Blackwell platform is becoming a key driver of its Data Center revenue growth. In the third quarter of fiscal 2026, the Data Center segment generated $51.
www.nasdaq.com
Will NVDA's Blackwell Platform Support Its Data Center Revenue Growth?
NVIDIA Corporation's NVDA Blackwell platform is becoming a key driver of its Data Center revenue growth.
www.nasdaq.com
NVIDIA Soars 39% in 2025: Will the Stock Carry Momentum in 2026?
NVIDIA Corporation NVDA shares have soared 38.
#NeumoraTherapeutics #Alzheimers #ClinicalTrials
www.nasdaq.com
Neumora Therapeutics Reports Encouraging Phase 1b Data For NMRA-511 In Alzheimer's Disease Agitation
(RTTNews) - Neumora Therapeutics, Inc. (NMRA) on Monday announced positive results from a Phase 1b study of NMRA-511 in patients with agitation associated with Alzheimer's disease (AD).
#NeumoraTherapeutics #Alzheimers #ClinicalTrials
www.nasdaq.com
Neumora Therapeutics Reports Encouraging Phase 1b Data For NMRA-511 In Alzheimer's Disease Agitation
(RTTNews) - Neumora Therapeutics, Inc.
#MultipleSclerosis #FDAApproval #GenericDrugs
www.nasdaq.com
ScinoPharm Wins First FDA Approval With Glatiramer Acetate Injection For Multiple Sclerosis
(RTTNews) - ScinoPharm Taiwan (TWSE: 1789) today announced that the U. S. FDA has approved its Glatiramer Acetate Injection, a generic version of Teva's Copaxone, for the treatment of adult patients with multiple sclerosis.
#MultipleSclerosis #FDAApproval #GenericDrugs
www.nasdaq.com
ScinoPharm Wins First FDA Approval With Glatiramer Acetate Injection For Multiple Sclerosis
(RTTNews) - ScinoPharm Taiwan (TWSE: 1789) today announced that the U.
#biopharmaceuticals #cancerresearch #clinicaltrials
www.nasdaq.com
HUTCHMED Begins Phase 3 Part Of Phase 2/3 Surufatinib-Camrelizumab Combo Study In Pancreatic Cancer
(RTTNews) - HUTCHMED (China) Ltd (HCM, HCM. L,0013. HK), a commercial-stage, biopharmaceutical company, announced on Monday that it has commenced the Phase III part of the Phase II/III trial to evaluate the efficacy of the combination of surufatinib combined with camrelizumab, nab-paclitaxel and gemcitabine as a first-line treatment for patients with metastatic pancreatic ductal adenocarcinoma or PDAC in China.
#biopharmaceuticals #cancerresearch #clinicaltrials
www.nasdaq.com
HUTCHMED Begins Phase 3 Part Of Phase 2/3 Surufatinib-Camrelizumab Combo Study In Pancreatic Cancer
(RTTNews) - HUTCHMED (China) Ltd (HCM, HCM.
#HawaiianAirlines #TravelInnovation #Sustainability
www.nasdaq.com
Hawaiian Airlines Unveils $600 Mln Plan To Upgrade Service And Support Sustainability
(RTTNews) - Hawaiian Airlines, a unit of Alaska Air Group Inc. (ALK) on Monday unveiled a more than $600 million, five-year investment plan to improve the guest experience across Hawai'i through airport upgrades, technology enhancements and aircraft interior retrofits, while expanding community and sustainability initiatives.
#ArtificialIntelligence #DrugDiscovery #Oncology
www.nasdaq.com
InSilico Signs US$888Mln Multi-Year Oncology Drug Discovery Deal With Servier
(RTTNews) - InSilico Medicine Cayman TopCo. (3696. HK), an artificial intelligence-driven drug discovery company, has announced a multi-year research and development collaboration valued at up to $888 million with France-based Servier for drug discovery and development in oncology.
#ArtificialIntelligence #DrugDiscovery #Oncology
www.nasdaq.com
InSilico Signs US$888Mln Multi-Year Oncology Drug Discovery Deal With Servier
(RTTNews) - InSilico Medicine Cayman TopCo.
www.nasdaq.com
GSK's Nucala Approved In China For Adult COPD Treatment
(RTTNews) - GSK plc (GSK, GSK. L) announced that China's National Medical Products Administration (NMPA) has approved Nucala (mepolizumab) as add-on maintenance treatment of adult patients with inadequately controlled chronic obstructive pulmonary disease or COPD characterised by raised blood eosinophils.
www.nasdaq.com
GSK's Nucala Approved In China For Adult COPD Treatment
(RTTNews) - GSK plc (GSK, GSK.
#Pharmaceuticals #ClinicalTrials #DrugDevelopment
www.nasdaq.com
Crinetics To Provide Update On PALSONIFY And Topline Results From Phase 2 Trial Of Atumelnant In CAH
(RTTNews) - Crinetics Pharmaceuticals, Inc. (CRNX) is scheduled to host a conference call to provide an update on its lead drug PALSONIFY's commercialisation and disclose topline results from the fourth cohort of its Phase 2 trial of Atumelnant in congenital adrenal hyperplasia or CAH, today.
#Pharmaceuticals #ClinicalTrials #DrugDevelopment
www.nasdaq.com
Crinetics To Provide Update On PALSONIFY And Topline Results From Phase 2 Trial Of Atumelnant In CAH
(RTTNews) - Crinetics Pharmaceuticals, Inc.
#Lithium #EnergyStorage #ElectricVehicles
www.nasdaq.com
Lithium Market Forecast: Top Trends for Lithium in 2026
The lithium market heads into 2026 after one of its most punishing years in recent memory, shaped by deep oversupply, weaker-than-expected electric vehicle demand and sustained price pressure.
#Lithium #EnergyStorage #ElectricVehicles
www.nasdaq.com
Lithium Market Forecast: Top Trends for Lithium in 2026
The lithium market heads into 2026 after one of its most punishing years in recent memory, shaped by deep oversupply, weaker-than-expected electric vehicle demand and sustained price pressure.
#OLED #CES2026 #DisplayTechnology
www.nasdaq.com
LG Display To Showcase Advanced OLED And Automotive Innovations At CES 2026
(RTTNews) - LG Display will present a full lineup of strategic OLED products at CES 2026, highlighting new technologies for both consumer and automotive applications.
#OLED #CES2026 #DisplayTechnology
www.nasdaq.com
LG Display To Showcase Advanced OLED And Automotive Innovations At CES 2026
(RTTNews) - LG Display will present a full lineup of strategic OLED products at CES 2026, highlighting new technologies for both consumer and automotive applications.
www.nasdaq.com
Hyundai Motor Group Outlines 2026 Vision
(RTTNews) - Hyundai Motor Group has shared its strategic vision for 2026, with Executive Chair Euisun Chung presenting priorities aimed at driving customer-focused transformation, strengthening ecosystem competitiveness, and advancing AI-driven innovation to meet evolving market dynamics.
www.nasdaq.com
Insilico Medicine Announces US$888 Mln Multi-Year Oncology Collaboration With Servier
(RTTNews) - Insilico Medicine announced that it has entered into a multi-year research and development (R&D) collaboration with Servier, an independent international pharmaceutical company governed by a foundation.
www.nasdaq.com
Insilico Medicine Announces US$888 Mln Multi-Year Oncology Collaboration With Servier
(RTTNews) - Insilico Medicine announced that it has entered into a multi-year research and development (R&D) collaboration with Servier, an independent international pharmaceutical company governed by a foundation.
#ArtificialIntelligence #Investing #ElectricVehicles
www.nasdaq.com
My 3 Favorite Artificial Intelligence Stocks to Buy Right Now
Tesla is technically an electric vehicle company, but that doesn't begin to scratch the surface.
Artificial intelligence (AI) is arguably the most significant advance in our society since the smartphone essentially put the internet in everyone's pocket, giving rise to the app economy, mobile payments, on-demand videos and music, and mobile commerce.
#ArtificialIntelligence #Investing #ElectricVehicles
www.nasdaq.com
My 3 Favorite Artificial Intelligence Stocks to Buy Right Now
Tesla is technically an electric vehicle company, but that doesn't begin to scratch the surface.
#ArtificialIntelligence #DataStorage #TechInnovation
www.nasdaq.com
A Once-in-a-Decade Investment Opportunity: The 3 Best AI Stocks to Buy in January 2026
Pure Storage is a leader in enterprise storage solutions, and its all-flash arrays pack more storage density and greater power efficiency than any competing product.
#ArtificialIntelligence #DataStorage #TechInnovation
www.nasdaq.com
A Once-in-a-Decade Investment Opportunity: The 3 Best AI Stocks to Buy in January 2026
Pure Storage is a leader in enterprise storage solutions, and its all-flash arrays pack more storage density and greater power efficiency than any competing product.
#Amazon #Investing #Technology
www.nasdaq.com
Is This a Rare Buying Opportunity for Amazon Stock?
Amazon (NASDAQ: AMZN) has been a reliable long-term performer, but the growth stock didn't have a spectacular 2025. The growth stock only gained 5% despite strong financial results throughout the year, and this mismatch makes Amazon look promising.
#Amazon #Investing #Technology
www.nasdaq.com
Is This a Rare Buying Opportunity for Amazon Stock?
Amazon (NASDAQ: AMZN) has been a reliable long-term performer, but the growth stock didn't have a spectacular 2025.
#ArtificialIntelligence #Networking #DataCenters
www.nasdaq.com
The Market May Be Underestimating This AI Trend, and These Stocks Are Set to Benefit
As AI clusters scale beyond 100,000 compute nodes, demand for high-speed, high-bandwidth, low-latency, reliable networking has soared dramatically.
#ArtificialIntelligence #Networking #DataCenters
www.nasdaq.com
The Market May Be Underestimating This AI Trend, and These Stocks Are Set to Benefit
As AI clusters scale beyond 100,000 compute nodes, demand for high-speed, high-bandwidth, low-latency, reliable networking has soared dramatically.
#QuantumComputing #Investing #TechIndustry
www.nasdaq.com
IonQ Stock in 5 Years: Moon Shot or Crash Landing?
It already works with large customers such as Hyundai, Microsoft Azure, and Google.
The discussion surrounding quantum computing and its potential use cases has dominated much of the tech headlines in 2025.
#QuantumComputing #Investing #TechIndustry
www.nasdaq.com
IonQ Stock in 5 Years: Moon Shot or Crash Landing?
It already works with large customers such as Hyundai, Microsoft Azure, and Google.
#QuantumComputing #Investing #TechIndustry
www.nasdaq.com
IonQ Stock in 5 Years: Moon Shot or Crash Landing?
It already works with large customers such as Hyundai, Microsoft Azure, and Google.
#AIInfrastructure #Investment #RenewableEnergy
www.nasdaq.com
This AI Infrastructure Play Could Double Your Money
Brookfield Corporation (NYSE: BN) might not be the most obvious AI infrastructure play at first glance. The global investment firm is more of an old-school company.
#AIInfrastructure #Investment #RenewableEnergy
www.nasdaq.com
This AI Infrastructure Play Could Double Your Money
Brookfield Corporation (NYSE: BN) might not be the most obvious AI infrastructure play at first glance.
#Biotech #CysticFibrosis #Investment
www.nasdaq.com
A Sionna Therapeutics (SION) Insider Sold 33,000 Shares for $1.5 Million
Sell size matched the median for recent disposals, and came as available capacity declined to near zero following a series of large transactions in 2025.
#Biotech #CysticFibrosis #Investment
www.nasdaq.com
A Sionna Therapeutics (SION) Insider Sold 33,000 Shares for $1.5 Million
Sell size matched the median for recent disposals, and came as available capacity declined to near zero following a series of large transactions in 2025.
#EmpireWind #EnergyInfrastructure #LegalChallenge
www.nasdaq.com
Equinor's Empire Offshore Wind Files Suit To Challenge U.S. Suspension Order
(RTTNews) - Equinor announced that Empire Offshore Wind LLC has filed a civil suit in the U. S. District Court for the District of Columbia on 2 January 2026, challenging the U.
www.nasdaq.com
2 Predictions for Pfizer in 2026
It might take a while longer, but Pfizer is on the path to recovery.
Is 2026 the year Pfizer (NYSE: PFE) finally turns things around.
www.nasdaq.com
2 Predictions for Pfizer in 2026
It might take a while longer, but Pfizer is on the path to recovery.
